[Crossed hepatotoxicity of erythromycin propionate and troleandomycin?]. 1988

J Y Luherne, and E A Pariente, and F Maitre

UI MeSH Term Description Entries
D008297 Male Males
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014217 Troleandomycin A macrolide antibiotic that is similar to ERYTHROMYCIN. Triacetyloleandomycin,Oleandocetin,TAO
D056486 Chemical and Drug Induced Liver Injury A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment. Drug-Induced Liver Injury,Liver Injury, Drug-Induced,Acute Liver Injury, Drug-Induced,Chemically-Induced Liver Toxicity,Drug-Induced Acute Liver Injury,Drug-Induced Liver Disease,Hepatitis, Drug-Induced,Hepatitis, Toxic,Liver Injury, Drug-Induced, Acute,Toxic Hepatitis,Acute Liver Injury, Drug Induced,Chemically Induced Liver Toxicity,Chemically-Induced Liver Toxicities,Disease, Drug-Induced Liver,Diseases, Drug-Induced Liver,Drug Induced Acute Liver Injury,Drug Induced Liver Disease,Drug Induced Liver Injury,Drug-Induced Hepatitides,Drug-Induced Hepatitis,Drug-Induced Liver Diseases,Drug-Induced Liver Injuries,Hepatitides, Drug-Induced,Hepatitides, Toxic,Hepatitis, Drug Induced,Injuries, Drug-Induced Liver,Injury, Drug-Induced Liver,Liver Disease, Drug-Induced,Liver Diseases, Drug-Induced,Liver Injuries, Drug-Induced,Liver Injury, Drug Induced,Liver Toxicities, Chemically-Induced,Liver Toxicity, Chemically-Induced,Toxic Hepatitides,Toxicities, Chemically-Induced Liver,Toxicity, Chemically-Induced Liver

Related Publications

J Y Luherne, and E A Pariente, and F Maitre
July 1988, Lancet (London, England),
J Y Luherne, and E A Pariente, and F Maitre
June 1981, Biochemical pharmacology,
J Y Luherne, and E A Pariente, and F Maitre
March 1969, The Journal of infectious diseases,
J Y Luherne, and E A Pariente, and F Maitre
February 1989, Revista clinica espanola,
J Y Luherne, and E A Pariente, and F Maitre
February 1960, Antibiotic medicine & clinical therapy (New York, NY),
J Y Luherne, and E A Pariente, and F Maitre
March 1978, American journal of diseases of children (1960),
J Y Luherne, and E A Pariente, and F Maitre
March 1980, JAMA,
J Y Luherne, and E A Pariente, and F Maitre
January 1994, Fundamental & clinical pharmacology,
J Y Luherne, and E A Pariente, and F Maitre
May 1979, British medical journal,
J Y Luherne, and E A Pariente, and F Maitre
January 1958, Antibiotics annual,
Copied contents to your clipboard!